Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving immune–vascular crosstalk for cancer immunotherapy
Yuhui Huang, Betty Y.S. Kim, Charles K. F. Chan, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 195-203
Open Access | Times Cited: 441

Showing 1-25 of 441 citing articles:

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai, Dianbo Liu, Miao Liu, et al.
Cancer Discovery (2020) Vol. 10, Iss. 6, pp. 783-791
Open Access | Times Cited: 1542
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 631
The clinical role of the TME in solid cancer
Nicolás A. Giraldo, Rafael Sanchez‐Salas, J. David Peske, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 45-53
Open Access | Times Cited: 558
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Muyue Yang, Jipeng Li, Ping Gu, et al.
Bioactive Materials (2020) Vol. 6, Iss. 7, pp. 1973-1987
Open Access | Times Cited: 555
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 544
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 536
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
Ming Yi, Dechao Jiao, Shuang Qin, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 507
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
Won Suk Lee, Hannah Yang, Hong Jae Chon, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1475-1485
Open Access | Times Cited: 473
Combining Nanomedicine and Immunotherapy
Yang Shi, Twan Lammers
Accounts of Chemical Research (2019) Vol. 52, Iss. 6, pp. 1543-1554
Open Access | Times Cited: 391
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 372
Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 324
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, et al.
Cell (2020) Vol. 181, Iss. 2, pp. 424-441.e21
Open Access | Times Cited: 309
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Zowi R. Huinen, Elisabeth J. M. Huijbers, Judy R. van Beijnum, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 8, pp. 527-540
Closed Access | Times Cited: 262
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai, Naifei Chen, Lingyu Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 261
Fighting Immune Cold and Reprogramming Immunosuppressive Tumor Microenvironment with Red Blood Cell Membrane-Camouflaged Nanobullets
Zhe Yang, Di Gao, Xiaoqing Guo, et al.
ACS Nano (2020) Vol. 14, Iss. 12, pp. 17442-17457
Closed Access | Times Cited: 230
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
Yuxiao Song, Yang Fu, Qi Xie, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 203
Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
Xichen Zheng, Zhaoxu Fang, Xiaomei Liu, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 5, pp. 2104-2115
Open Access | Times Cited: 195
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Diana Klein
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 173
Smart Nanotherapeutic Targeting of Tumor Vasculature
Zifu Li, Chunzhi Di, Suping Li, et al.
Accounts of Chemical Research (2019) Vol. 52, Iss. 9, pp. 2703-2712
Closed Access | Times Cited: 169
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Jackson G. Egen, Wenjun Ouyang, Lawren C. Wu
Immunity (2020) Vol. 52, Iss. 1, pp. 36-54
Open Access | Times Cited: 167
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 165
anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
Shaochuan Liu, Tingting Qin, Zhujun Liu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 154
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Lionel Aurelien Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 69-77
Open Access | Times Cited: 150
Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation
Yaxin Zhou, Xiaomeng Ren, Zhaosheng Hou, et al.
Nanoscale Horizons (2020) Vol. 6, Iss. 2, pp. 120-131
Open Access | Times Cited: 145
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi, Ronald J. Fecek, Jennifer L. Taylor, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e001906-e001906
Open Access | Times Cited: 122
Page 1 - Next Page

Scroll to top